tapebrief
MMM · Q2 2025

MMM · Q3 2025 Earnings

Cautious

3M

Reported October 21, 2025

30-second summary

30-second take. 3M delivered Q3 revenue of $6.52B (+3.5% YoY), adjusted EPS of $2.19, and adjusted operating margin of 24.7% (+170bps YoY), and raised FY2025 adjusted EPS guidance to $7.95–$8.05 from $7.75–$8.00. Organic growth of 3.2% comfortably cleared the ~2% bar the H1 print had put at risk, and all three segments grew — including T&E adjusted organic flipping to +3.6% from a down H1. The raise is real and earned. The operating cash flow band was narrowed (low end raised $100M to $5.2B, high end clipped $100M to $5.4B; midpoint unchanged at $5.3B), suggesting higher conviction. A new multi-year manufacturing/distribution restructuring program was disclosed with Q3/Q4 charges of $14M/$15M and no size yet attached.

Headline numbers

EPS

Q3 FY2025

$2.19

Revenue

Q3 FY2025

$6.52B

+3.5% YoY

Gross margin

Q3 FY2025

41.8%

Free cash flow

Q3 FY2025

$1.31B

Operating margin

Q3 FY2025

22.2%

Key financials

Q3 FY2025
MetricQ3 FY2025YoYQ2 FY2025QoQ
Revenue$6.52B+3.5%$6.34B+2.7%
EPS$2.19—$2.16+1.4%
Gross margin41.8%—42.5%-70bps
Operating margin22.2%—18.0%+420bps
Free cash flow$1.31B———

Guidance

FY2025 EPS guidance raised to $7.95-$8.05 from $7.75-$8.00, reflecting outperformance in organic growth (3.2% vs ~2% guidance) and margin expansion; full-year adjusted total and organic sales growth targets reaffirmed with subtle language upgrades.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

New guidance

MetricPeriodGuideYoY
Adjusted operating income margin expansionFY 2025180 bps to 200 bps—

Changes to prior guidance

MetricPeriodPrior guideNew guideΔResult
Adjusted EPS
FY 2025
$7.75 to $8.00$7.95 to $8.05midpoint +$0.15 (low +$0.20, high +$0.05)Raised
Adjusted organic sales growth
FY 2025
~2.0%>2%guidance floor raised slightly; language shift from '~2.0%' to '>2%'Raised

Reaffirmed unchanged this quarter: Adjusted total sales growth (>2.5%), Adjusted operating cash flow ($5.2 to $5.4 billion)

Segment KPIs

Q3 FY2025
SegmentQ3 FY2025YoY
Safety and Industrial$2.917B+5.4%
Transportation and Electronics$2.191B+2.4%
Consumer$1.312B+0.9%

Other KPIs

Q3 FY2025
SegmentQ3 FY2025
Adjusted organic sales growth3.2%
Adjusted operating margin24.7%
Adjusted operating margin expansion170 bps YoY
Operating cash flow$1.8 billion
Adjusted free cash flow$1.3 billion
Shareholder returns$0.9 billion
Safety and Industrial adjusted operating margin26.3%
Transportation and Electronics adjusted operating margin24.3%

Management tone

Q2 cautious tariff/Europe hedging → Q3 confidence backed by execution.

The back-half acceleration management hedged on in Q2 actually showed up. Last quarter the bridge from 1.5% H1 organic to ~2.5% H2 was framed as dependent on auto turning from down to "flattish" and Europe holding. Q3 delivered 3.2% organic, T&E adjusted organic flipped to +3.6%, and EMEA returned to growth (organic +1.3%, adjusted +2.2%) after a negative H1 (YTD EMEA organic -2.1%). The guidance language change from "~2%" to ">2%" reads as confidence that wasn't there in July, and the EPS-low raise of $0.20 vs the high raise of $0.05 is consistent with downside being taken off the table without claiming upside surprise.

Restructuring is being repositioned as continuous architecture rather than a discrete program. In Q&A, Bill characterized the new manufacturing/distribution/business-process redesign as "a longer-term, thoughtful redesign… not a big bang approach, but phased actions aligned to long-term growth agenda." That language is a deliberate contrast with the prior enterprise restructuring program. Management declined to size it and deferred framework disclosure to Q4. The Q3 $14M and Q4 ~$15M charges are placeholders; the real number is not on the table yet.

Divestitures reframed from portfolio cleanup to value discipline. Asked whether 3M would execute toward the 10% of profit centers identified as non-core or stay in a "2-3% envelope," Bill said the precision grinding divestiture (sub-1% revenue, 7 factories) was the template — sell where shareholder value exceeds internal value, no commitment to scale or speed. That is more disciplined than the Q2 framing, which left divestiture pace ambiguous.

The 25% margin target by 2027 was reiterated with a specific build. $1B above-macro growth target: ~$100M in 2025, $300M in 2026, $600M in 2027. 360bps of margin expansion over 2024–2027, with 180–200bps coming this year. Management says they have found more supply chain, G&A, and factory-spend opportunities than identified at the Investor Day. Whether 25% gets pulled forward to 2026 was floated by UBS — Anurag did not commit but did not push back either.

Q&A highlights

Scott Davis · Milius Research

What is driving the strong new product introductions and results without significant additional spending? Has compensation culture changed? Can 3M grow at 4-6% by creating new product categories rather than just incremental Class 3 products?

Bill emphasized greater pace, rigor, and urgency in innovation with latent ideas from teams. Investment up only 30 basis points. 80% of launches are Class 3 (line extensions), 20% are Class 4/5 (adjacent/new markets). More Class 4/5 expected in pipeline. Revenue from products launched in last 5 years up 30% in Q3, 16% YTD. Company not disclosing specific growth targets beyond macro outperformance, but expects growth acceleration over time as more products launch.

70 new products launched in Q3, 196 YTD, targeting 250+ for full year vs. 215 goalNPI revenue up 30% in Q3, 16% YTD, tracking to high teens for full year130 products in front-end funnel, ~1,000 ideas in pipelineR&D spend on new product development increased from <30% to 35-36%

Jeff Sprague · Vertical Research

Is this a two to three-year large restructuring project? How large could it be? What should investors expect in 2026 regarding these new restructuring actions versus the prior enterprise-wide program?

Bill characterized this as a longer-term, thoughtful redesign of manufacturing, distribution, and business process services unlike the prior enterprise restructuring focused on short-term actions. Not a big bang approach, but phased actions aligned to long-term growth agenda. Will evolve thoughtfully to avoid disrupting momentum. Q3: $14M charge; Q4: ~$15M expected. More framework details will be provided in Q4 2025. Will not size the program today, but ongoing process that will unfold over time.

Q3 charge: $14 million for transformation effortsQ4 expected charge: approximately $15 millionDiffers from prior enterprise restructuring programFocuses on manufacturing network, distribution network, and business process services redesign

Amit Mehrotra · UBS

On 2026 framework: can you detail the moving parts (3% growth, 35% incrementals, productivity) to reach 25% margin target by 2027? Could the 25% target be pulled forward to 2026? On divestitures: can you execute more toward the 10% of profit centers identified, or stay in 2-3% envelope?

Anurag confirmed feeling good about 25% margin target by 2027. Over three years (2024-2027): 360 bps margin expansion; YTD 180-200 bps in 2025. Expects continued outperformance vs. macro, $300M incremental revenue growth in 2026 vs. $100M in 2025. More opportunities identified in supply chain, G&A, and factory spend than expected at Investor Day. Bill stated divestiture process is ongoing and disciplined. Will only sell businesses where shareholder value exceeds internal value. Precision grinding business was less than 1% revenue with 7 factories, clearly not core fit. Process will unfold over time; not committing to 2-3% or 10% targets.

2025 margin expansion: 180-200 bps (vs. 360 bps over 3 years to 2027)2026 growth above macro: $300 million (vs. $100M in 2025)3-year productivity target: $1 billion ($100M 2025, $300M 2026, $600M 2027)Precision grinding divestiture: <1% revenue, 7 factories, not dilutive to earnings

Steve Tusa · J.P. Morgan

Q4 EPS implied run rate appears much lower than Q3 ($2.19). Is there significant seasonal drop-off beyond normal? You mentioned backlog provides 25% Q4 coverage, which seems positive. How much of the $1B revenue growth above macro over 3 years have you booked this year?

Anurag confirmed typical Q3-Q4 seasonal patterns: $250M lower volume (back-to-school, industrial seasonality), factory shutdowns impact absorption. Additional headwinds in Q4: $10M higher investments (stepped up from $175M to $185M) and increased tariffs. However, first 20 days of Q4 and backlog coverage suggest good trends ahead. For billion-dollar growth above macro: ~$100M booked in 2025, targeting $300M in 2026. Q4 margin expansion expected at 100 bps midpoint, potentially 150 bps if volume/margin performance continues.

Typical Q3-Q4 volume decline: $250 million2025 total R&D investment increased from $175M to $185MTariff headwinds increase in Q4$1B above-macro growth: ~$100M YTD 2025, $300M targeted 2026, $600M 2027

Nicole DeBlaise · Deutsche Bank

Electronics came in ahead of expectations - what drove that outperformance and was there timing between Q3/Q4? Geographically, what drove acceleration in China (mid-singles H1 to high-singles Q3) and Europe improvement?

Bill attributed electronics outperformance to penetration of mainstream market (80% of market) with new products; historically 3M served premium segment. Won content with major mainstream player for optically clear adhesives in smartphones and low-sparkle film for notebooks. For China: 8% growth in Q3 exceeded expectations; team expected softening but saw acceleration. Growth attributed to organizational model changes, operational excellence, and commercial effectiveness. About 50% domestic, 50% export. China exports up ~8% in September. Half of growth from self-help (operational/commercial excellence), half from market. Europe improved from down 1% H1 to up 2% Q3, driven by personal safety and communication solutions.

Electronics: ~10% of company sales, mid-single-digit growth in H1 and Q3Electronics penetration shifting from premium to mainstream market (80% of total)China Q3 growth: ~8%, exceeding expectations; expected to moderate slightly in Q4

Answers to last quarter's watch list

Organic sales growth accelerating from 1.5% H1 to ~2.5% H2 pace — Q3 delivered 3.2%, well above the ~2% bar; FY organic guide language firmed from "~2.0%" to ">2%".
Resolved positively
T&E returning to positive YoY growth — Q3 adjusted organic came in at +3.6% (GAAP organic +1.8%) after a down H1, comfortably positive rather than just "flattish"; electronics led, driven by mainstream-market design wins.
Resolved positively
European auto-build trajectory — EMEA organic returned to growth in Q3 at +1.3% (adjusted +2.2%) after a negative H1 (YTD EMEA organic -2.1%); management attributed the lift to personal safety and communication solutions, with Europe auto still characterized as a weakness offset by other categories. Auto wasn't reflagged as a watch area, so the risk has receded, but it wasn't directly addressed either.
Continue monitoring
OTIF progress toward high-80s year-end target — disclosed at 91.6% in Q3, up 200bps sequentially and 300bps YoY, with management noting four consecutive months above 90% — the highest OTIF in 20+ years.
Resolved positively
PFAS litigation developments (Vermont trial in November, property damage ranges) — no update in the press release; not raised in Q&A. The Vermont trial sits ahead of the next print, so silence here is unsurprising but unsatisfying.
Continue monitoring
Pricing realization holding ~70bps; margin guide intact — Bill confirmed pricing is tracking to ~70bps for the year (50bps H1, ~90bps H2), with the FY margin expansion floor raised from +150bps to +180bps and the high end held at +200bps.
Resolved positively

What to watch into next quarter

Q4 organic growth delivering at least +2% to validate the ">2%" FY guide. Q4 typically sees a $250M volume step-down; management is guiding +100bps margin midpoint with +150bps upside — a print below +100bps would suggest the back-half momentum stalled.

The Q4 framework disclosure on the new manufacturing/distribution transformation program. Management deferred sizing; investors should expect a multi-year charge envelope and 2026 EPS impact quantification. A program that materially exceeds the $14M/$15M Q3/Q4 placeholder run-rate would matter.

PFAS — Vermont property-damage trial outcome and any updated reserve disclosure in the 10-Q. Verdict or settlement before year-end could move the GAAP earnings picture materially.

Whether 2026 commentary in Q4 commits to the $300M above-macro revenue and any pull-forward of the 25% margin target. Anurag did not push back on the UBS question about 25% in 2026; if Q4 guidance frames 2026 margins at 24%+, the 2027 target is effectively at risk of being moved up.

Adjusted operating cash flow Q4 print — whether the narrowed $5.2–$5.4B band holds. The low end was raised and high end clipped; a Q4 cash print near the new floor would still validate the tightened range, but a miss below $5.2B would be a credibility hit on a guide management just expressed conviction in.

Sources

  1. 3M Q3 2025 press release (Form 8-K Exhibit 99.1), SEC filing — https://www.sec.gov/Archives/edgar/data/66740/000006674025000086/q32025-8kerexx991.htm
  2. 3M Q3 2025 earnings call Q&A excerpts.

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.